Acura Pharmaceuticals Inc: Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K

(marketscreener.com) TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT This AMENDMENT #6 TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT dated June 28, 2019 between Acura Pharmaceuticals, Inc. , a New York corporation, having a place of business at 616 N. North Court, Suite 120, Palatine, IL 60067, and...https://www.marketscreener.com/quote/stock/ACURA-PHARMACEUTICALS-IN-120789192/news/Acura-Pharmaceuticals-TO-LICENSE-DEVELOPMENT-AND-COMMERCIALIZATION-AGREEMENT-Form-8-K-44213365/?utm_medium=RSS&utm_content=20230628